Summit Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Buy
5,096
+165
+3% +$61.2K 0.02% 642
2026
Q1
$1.44M Buy
4,931
+1,504
+44% +$494K 0.02% 664
2025
Q4
$1.2M Buy
3,427
+599
+21% +$202K 0.02% 605
2025
Q3
$914K Buy
+2,828
New +$880K 0.01% 679

Other funds holding ELV

Summit Financial's ELV Position: Q2 2026 in Review

Summit Financial increased its Elevance Health (ELV) stake by 3.3% in Q2 2026, buying an estimated $61.2K and bringing the position to 5,096 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #642.

Summit Financial first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Summit Financial held 5,096 shares of Elevance Health worth $1.97M as of Q2 2026.
  • Summit Financial bought 165 Elevance Health shares in Q2 2026, an estimated $61.2K.
  • Elevance Health made up 0.02% of Summit Financial's portfolio in Q2 2026, its #642 holding.
  • Summit Financial first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.